Feature Stories
Learn about new initiatives underway to overcome ovarian cancer and meet people who are committed to making a difference.
Stories found here are from Seeds of Hope, the monthly e‑newsletter.
Women with ovarian cancer are talking on OVdialogue, a new online community introduced earlier this month at the Ovarian Cancer Canada Walk of Hope. Nearly a year in the making, OVdialogue enables women confronting the disease to connect with one another for advice and encouragement.
Even as August gives way to the dog days of summer, the community surrounding this important cause is ramping up efforts. Presently, volunteers and committees throughout the country are preparing for September, Ovarian Cancer Awareness Month.
Meet Houda, recipient of the 2017 Peggy Truscott Award of Hope
When Dr. Jim Petrik read about a new support group starting in his town, he reached out to the organizer immediately to commend her efforts in bringing people together. That was when he first connected with Frances Vanover, a woman living with ovarian cancer. After years of keeping in touch, they met in person and hatched a plan to bring about the first Ovarian Cancer Canada Walk of Hope in Guelph.
When Elly Mayday began modelling at age 23, she used her career as a platform for promoting body positivity; even before the idea was embraced by popular culture. She blazed a trail, inspiring women to love themselves just as they are.
It’s been almost two years since Yaya Jean learned she had ovarian cancer. Her family felt helpless under the weight of her diagnosis.
Last year, sisters Wendy Sutherland and Joanne Gasper received the Peggy Truscott Award at the Ovarian Cancer Canada Walk of Hope in their city of Regina, Saskatchewan.
A group of advocates is heading to Ottawa to demand that more be done about ovarian cancer in Canada. Stand with them. You can participate right now, from wherever you are.
Two major organizations in the charitable sector, the Canadian Cancer Society and the Canadian Breast Cancer Foundation, recently announced their official merger.
When she was diagnosed with ovarian cancer, Sue Deacon left no stone unturned as she searched for more information and the latest clinical trials. Her mother had passed away from the same disease and Sue wondered if her own diagnosis was the result of a hereditary predisposition.